目录
- Commentary of the mRNA vaccines COVID-19
- Regulatory role of long non coding RNAs (lncRNAs) in neurological disorders:From novel biomarkers to promising therapeutic strategies
- Relationship and improvement strategies between drug nanocarrier characteristics and hemocompatibility:What can we learn from the literature
- Use of graphene-based materials as carriers of bioactive agents
- Role of the cation-chloride-cotransporters in the circadian system
- Anti-EpCAM functionalized graphene oxide vector for tumor targeted siRNA delivery and cancer therapy
- Enhanced delivery efficiency and sustained release of biopharmaceuticals by complexation-based gel encapsulated coated microneedles:rhIFN α-1b example
- Synthetic anti-angiogenic genomic therapeutics for treatment of neovascular age-related macular degeneration
- A practical strategy to subcutaneous administered in-situ gelling co-delivery system of arsenic and retinoic acid for the treatment of acute promyelocytic leukemia
- Investigating the crucial roles of aliphatic tails in disulfide bond-linked docetaxel prodrug nanoassemblies
- Spatiotemporally co-delivery of triple therapeutic drugs via HA-coating nanosystems for enhanced immunotherapy